This compound is an Fmoc-protected polyethylene glycol (PEG) linker used in solid-phase peptide synthesis. It features a fluorenylmethoxycarbonyl (Fmoc) protecting group, an ether-containing PEG spacer, and a terminal carboxylic acid for conjugation.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 166108-71-0
1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azapentadecan-15-oic acid
Pharmaceutical intermediate for PEGylated compounds
23-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3,6,9,12,15,18,21-heptaoxatricosanoic acid
PEGylated Fmoc-protected amino acid reagent
2-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)acetic acid
Research compound for conjugation
Fmoc-AEEA-AEEA
peptide synthesis intermediate
5-Amino-4-cyanopyrazole
pharmaceutical intermediate
(23S,50S)-50-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
peptide synthesis intermediate
(R)-1-(4-Fluorophenyl)-1-propanol
pharmaceutical intermediate
(Triphenylphosphoranylidene)acetonitrile
Pharmaceutical intermediate
2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]acetic acid
XQPYRJIMPDBGRW-UHFFFAOYSA-N
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCOCCOCC(=O)O